Company news

Telesta Therapeutics Inc news in 2015

Telesta Therapeutics Inc's news releases, calls and decks from 2015, newest first.

View company

Telesta Therapeutics Corporate Update

December 14, 2015

Telesta Therapeutics Announces Results of the FDA Advisory Committee Vote

November 19, 2015

Telesta Therapeutics Inc. Announces Results of Annual General Meeting of Shareholders

November 16, 2015

Telesta Therapeutics Publishes its Q1, 2016 Financial Statements and Provides Corporate Updates

November 12, 2015

Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA(1) for the treatment of non-muscle invasive bladder cancer in major ex-United States territories

October 28, 2015

Telesta Therapeutics Appoints Brian J. Groch as Chief Commercial Officer

October 8, 2015

Telesta Announces FDA Advisory Committee Date for MCNA1

September 28, 2015

Telesta Therapeutics Publishes its Annual Consolidated Financial Statements and Provides Corporate Updates

September 14, 2015

Telesta Receives FDA BLA Filing Notification Letter and Priority Review Designation for MCNA(1)

August 28, 2015

Telesta Therapeutics Closes US$28.6 Million Private Placement

August 19, 2015

Telesta Therapeutics Announces South Korean Partnership for MCNA & Concurrent Private Placement

July 20, 2015

Telesta Therapeutics Submits Biologics License Application (BLA) to the U.S. FDA

June 30, 2015

Telesta Therapeutics Announces Issuance of Key U.S. MCNA Composition of Matter Patent

June 3, 2015

Telesta Therapeutics Publishes its Nine Month Financial Results to March 31, 2015 and Provides Corporate Updates

May 14, 2015

Telesta Therapeutics Provides Key Corporate Updates

April 27, 2015

Telesta Therapeutics Publishes its 6 Month Financial Results to December 31, 2014 and Provides Important Corporate Updates

February 13, 2015